
CalciMedica, Inc.
CALC·NASDAQ
Last updated as of 2026-04-19 01:41 EST. Stock price information is sourced from TradingView and reflects real-time market prices.
Insights
Calculator
News
CALC stock price change
On the last trading day, CALC stock closed at 0.60 USD, with a price change of -1.15% for the day.
Trade stock perpsTrending stocks
About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn moreCALC key data
Previous close0.60 USD
Market cap9.49M USD
Volume71.90K
P/E ratio-
Dividend yield (TTM)0.00%
Dividend amount-
Last ex-dividend date-
Last payment date-
EPS diluted (TTM)-1.97 USD
Net income (FY)−29.56M USD
Revenue (FY)0.00 USD
Next report dateMay 18, 2026
EPS estimate-
Revenue estimate-
Shares float7.57M
Beta (1Y)0.27

CalciMedica, Inc. overview
CalciMedica, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate, Auxora, helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.
Sector
Health technology
Industry
Biotechnology
CEO
Rachel Anne Leheny
Headquarters
La Jolla
Website
calcimedica.com
Founded
2007
Employees (FY)
16
Change (1Y)
+2 +14.29%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
−1.85M USD
CALC stock price forecast
According to technical indicators for CALC stock, the price is likely to fluctuate within the range of 0.69–0.72 USD over the next week. Market analysts predict that the price of CALC stock will likely fluctuate within the range of 0.67–0.74 USD over the next months.
Based on 1-year price forecasts from 30 analysts, the highest estimate is 1.59 USD, while the lowest estimate is 0.47 USD.
For more information, please see the
CALC stock price forecast
page.
